NCT06159322View on ClinicalTrials.gov

Characterizing Response to Antipsychotics in Schizophrenia

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 30, 2024

Study Completion Date

January 30, 2024

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Olanzapine

Antipsychotic medication

DRUG

Clozapine

Antipsychotic medication

Trial Locations (1)

K1Z 7K4

RECRUITING

The Royal's Institute of Mental Health Research, Ottawa

All Listed Sponsors
collaborator

The Royal's Institute of Mental Health Research

OTHER

lead

The Royal Ottawa Mental Health Centre

OTHER